Lab testing giant, approaching $500M in revenue, welcomes new CEO

NeoGenomics was under interim CEO leadership since March.

  • By Business Observer Staff
  • | 11:10 a.m. August 12, 2022
(File photo)
(File photo)
  • Charlotte–Lee–Collier
  • Share

Fort Myers cancer-focused genetic testing services and oncology contract research firm NeoGenomics released its second-quarter earnings report last week, including some statements about the firm’s new CEO, Chris Smith.

 

Continue reading your article
with a Business Observer subscription.
What's included:
  • ✓ Unlimited digital access to BusinessObserverFL.com
  • ✓ E-Newspaper app, digital replica of print edition
  • ✓ Mailed print newspaper every Friday (optional)
  • ✓ Newsletter of daily business news
Subscribe

Already subscribed? Sign in.

Latest News

  • April 2, 2026
Sarasota Doctors Hospital names new COO
  • April 2, 2026
Babcock Ranch shopping center gets refinance
  • April 2, 2026
Report: Childhood poverty pockets remain in region amid Florida decline
  • April 2, 2026
Hillsborough to spend $70M on stormwater drainage improvements

Sponsored Content